Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection? (Q41715212)

7 October 2017

1 reference

title

Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection? (English)

1 reference

7 October 2017

Tulenko TN

1

1 reference

7 October 2017

Laury-Kleintop L

series ordinal

2

1 reference

7 October 2017

Walter MF

series ordinal

3

1 reference

7 October 2017

Mason RP

series ordinal

4

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

International Journal of Cardiology

7 October 2017

published in

1 reference

7 October 2017

volume

62 Suppl 2

1 reference

7 October 2017

page(s)

S55-66

1 reference

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

High-density lipoproteins: epidemiologic profile and risks of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Sterol, Structure and Membrane Function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Cholesterol and the cell membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Atherosclerosis alters the composition, structure and function of arterial smooth muscle cell plasma membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Cell biology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Alterations of hepatic Na + ,K + -ATPase and bile flow by estrogen: Effects on liver surface membrane lipid structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Membrane microviscosity and human platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Cholesterol modulates organic cation transport activity and lipid fluidity in rat renal brush-border membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Alterations in basal and serotonin-stimulated calcium permeability and vasoconstriction in atherosclerotic aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Excess membrane cholesterol alters calcium channels in arterial smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Mechanism of antiatherogenic action of calcium antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Are calcium ion antagonists effective anti-atherogenic agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Cellular calcium and atherosclerosis: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Membrane interaction of calcium channel antagonists modulated by cholesterol. Implications for drug activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Manidipine regulates the transcription of cytokine genes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900242-8

7 January 2021

10.1016/S0167-5273(97)00242-8

Identifiers

DOI

1 reference

7 October 2017

1 reference